S5L (p.Ser5Leu) variant of KRT5 (Keratin, type II cytoskeletal 5)

S5L (p.Ser5Leu) in KRT5 (Keratin, type II cytoskeletal 5) is a missense change. Clinical records from EBI and UniProt describe it as pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.43 / 1. The record also includes population frequency data and structural context.

S5L (p.Ser5Leu) variant details